Perspectives on introduction and implementation of new point-of-care diagnostic tests

Kara M. Palamountain, Jeff Baker, Elliot P. Cowan, Shaffiq Essajee, Laura T. Mazzola, Mutsumi Metzler, Marco Schito, Wendy S. Stevens, Gloria J. Young, Gonzalo J. Domingo*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations


In recent years, there has been significant investment from both the private and public sectors in the development of diagnostic technologies to meet the need for human immunodeficiency virus (HIV) and tuberculosis testing in low-resource settings. Future investments should ensure that the most appropriate technologies are adopted in settings where they will have a sustainable impact. Achieving these aims requires the involvement of many stakeholders, as their needs, operational constraints, and priorities are often distinct. Here, we discuss these considerations from different perspectives representing those of various stakeholders involved in the development, introduction, and implementation of diagnostic tests. We also discuss some opportunities to address these considerations.

Original languageEnglish (US)
Pages (from-to)S181-S190
JournalJournal of Infectious Diseases
Issue numberSUPPL. 2
StatePublished - May 15 2012

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases


Dive into the research topics of 'Perspectives on introduction and implementation of new point-of-care diagnostic tests'. Together they form a unique fingerprint.

Cite this